These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 421352)

  • 21. Dubin-Johnson Syndrome.
    Noe Del Cueto-Aguilera A; García-Compean D; Scharrer Cabello SI; González-González JA
    Am J Gastroenterol; 2020 Sep; 115(9):1386. PubMed ID: 32886872
    [No Abstract]   [Full Text] [Related]  

  • 22. Inherited disorders of bilirubin clearance.
    Memon N; Weinberger BI; Hegyi T; Aleksunes LM
    Pediatr Res; 2016 Mar; 79(3):378-86. PubMed ID: 26595536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of chronic idiopathic jaundice (Dubin-Johnson syndrome). II. Evaluation of a large family with the trait.
    Butt HR; Anderson VE; Foulk WT; Baggenstoss AH; Schoenfield LJ; Dickson ER
    Gastroenterology; 1966 Nov; 51(5):619-30. PubMed ID: 5926936
    [No Abstract]   [Full Text] [Related]  

  • 24. Neonatal Dubin-Johnson syndrome with severe cholestasis: effective phenobarbital therapy.
    Kimura A; Ushijima K; Kage M; Mahara R; Tohma M; Inokuchi T; Shibao K; Tanaka N; Fujisawa T; Ono E
    Acta Paediatr Scand; 1991 Mar; 80(3):381-5. PubMed ID: 2035335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent cholestasis following cholecystectomy: a case of Dubin-Johnson syndrome.
    Renault M; Nowicki M
    J Pediatr; 2010 Jul; 157(1):167. PubMed ID: 20227718
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical expression of co-inherited Dubin-Johnson and thalassaemic heterozygous states.
    Fretzayas A; Kitsiou S; Papadopoulou A; Nicolaidou P
    Dig Liver Dis; 2007 Apr; 39(4):369-74. PubMed ID: 16563888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sn-mesoporphyrin suppression of hyperbilirubinemia in EHBR/Eis rats, an animal model of Dubin-Johnson syndrome.
    Drummond GS; Kappas A
    Pharmacology; 1998 Mar; 56(3):158-64. PubMed ID: 9532616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic fate of exogenous delta-aminolevulinic acid in Dubin-Johnson syndrome.
    Kondo T; Kuchiba K; Shimizu Y
    J Lab Clin Med; 1979 Sep; 94(3):421-8. PubMed ID: 469378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3 cases of Dubin-Johnson syndrome occurring in familiies.
    Irino S; Kitajima K; Sezaki T; Ozaki Y; Hasegawa M
    Nihon Rinsho; 1969 Jul; 27(7):1890-5. PubMed ID: 5391078
    [No Abstract]   [Full Text] [Related]  

  • 30. In silico screening and analysis of single-nucleotide polymorphic variants of the ABCC2 gene affecting Dubin-Johnson syndrome.
    Sharma P; Sharma S
    Arab J Gastroenterol; 2022 Aug; 23(3):172-187. PubMed ID: 35477852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia.
    Weiss JS; Gautam A; Lauff JJ; Sundberg MW; Jatlow P; Boyer JL; Seligson D
    N Engl J Med; 1983 Jul; 309(3):147-50. PubMed ID: 6866015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy, oral contraceptives, and chronic familial jaundice with predominantly conjugated hyperbilirubinemia (Dubin-Johnson syndrome).
    Cohen L; Lewis C; Arias IM
    Gastroenterology; 1972 Jun; 62(6):1182-90. PubMed ID: 5050316
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic clearance of unconjugated bilirubin in cholestatic liver diseases.
    Bloomer JR; Berk PD; Howe RB
    Am J Dig Dis; 1974 Jan; 19(1):9-14. PubMed ID: 4809035
    [No Abstract]   [Full Text] [Related]  

  • 34. Dubin-Johnson syndrome in immature sheep.
    Cornelius CE; Osburn BI; Gronwall RR; Cardinet GH
    Am J Dig Dis; 1968 Dec; 13(12):1072-6. PubMed ID: 5749221
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutation spectrum and biochemical features in infants with neonatal Dubin-Johnson syndrome.
    Kim KY; Kim TH; Seong MW; Park SS; Moon JS; Ko JS
    BMC Pediatr; 2020 Aug; 20(1):369. PubMed ID: 32758197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment of bromosulfophthalein clearance by bile salt administration in normal volunteers and patients with Dubin-Johnson syndrome.
    Bar-Meir S; Levy R; Halperin Z; Levy-Gigi C; Gilat T
    Isr J Med Sci; 1982 Feb; 18(2):211-4. PubMed ID: 7068349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biliary excretion of conjugated sulfobromophthalein (BSP) in constitutional conjugated hyperbilirubinemias.
    Abe H; Okuda K
    Digestion; 1975; 13(5):272-83. PubMed ID: 1205014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dubin-Johnson syndrome: molecular basis and pathogenesis].
    Mzabi-Regaya S; Chadli-Debbiche A; Ben Brahim E; Gritli S; Goutallier-Ben Fadhel C; Khalfallah MT
    Tunis Med; 2002 Apr; 80(4):228-32. PubMed ID: 12416362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia.
    Keppler D
    Drug Metab Dispos; 2014 Apr; 42(4):561-5. PubMed ID: 24459177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital dyserythropoietic anemia and the Dubin-Johnson syndrome. A case report.
    Clauvel JP; Erlinger S
    Gastroenterology; 1974 Oct; 67(4):686-90. PubMed ID: 4412600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.